1-3 of 3
Lars-Olof Muegge
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Comorbidities and Prospective Functional Geriatric Assessment Tools (CF-GA) As an Aide to Understand Outcome, Therapy Tolerance, Side Effects and Clinical Trial Eligibility in Multiple Myeloma (MM) Patients (pts)

Free
Alexander Zober, MD, Mandy Möller, Sandra-Maria Dold, Gabriele Ihorst, PhD, Stefanie Hieke, PhD, Jochen Knaus, Milena Pantic, PhD, Barbara Deschler-Baier, MD, Stefan Knop, Hermann Einsele, Christian Langer, Lars-Olof Muegge, MD, Wolfram Poenisch, MD, Justus Duyster, MD PhD, Martin Schumacher, PhD, Ralph M. Waesch, MD PhD, Monika Engelhardt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5616.
https://doi.org/10.1182/blood.V126.23.5616.5616
Published: 2015
Journal Articles

Long-Term Survival after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation in AML-Patients Is Consistently Sustained and Influenced by Donor Type Selection.

Free
Herbert G. Sayer, MD, Lars-Olof Muegge, MD, Sebastian Scholl, MD, Kristina Schilling, MD, Anne Klink, Volker Schmidt, Klaus Hoeffken, MD
Journal: Blood
Blood (2007) 110 (11): 5087.
https://doi.org/10.1182/blood.V110.11.5087.5087
Published: 2007
Journal Articles

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

Free
Anne Klink, Christoph Kasper, M.D., Sebastian Scholl, M.D., Lars-Olof Muegge, M.D., Kristina Schilling, Anja Markusch, Klaus Hoeffken, M.D., Herbert G. Sayer, M.D.
Journal: Blood
Blood (2004) 104 (11): 1833.
https://doi.org/10.1182/blood.V104.11.1833.1833
Published: 2004